HK2 and osteosarcoma: In addition, RBM15 interacts with circ-CTNNB1 to enhance the expression of HK2, GPI and PGK1 in an m6A modification-dependent manner, leading to the promotion of the glycolytic process and the development of osteosarcoma [39].